MedPath

Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM)

Active, not recruiting
Conditions
Coronary Heart Disease
Registration Number
NCT02803411
Lead Sponsor
Yonsei University
Brief Summary

To describe the natural history of the coronary atherosclerotic plaque development and progression over time by CCTA with demographic and laboratory data for refinement of risk stratification of patients referred for CCTA.

Detailed Description

All PARADIGM study patients underwent initial and follow-up CCTA based on order from their primary physician. Demographic data, targeted medical history, cardiovascular risk factors, and laboratory data was prospectively collected in electronic case report forms (eCRFs) at the time of the initial CCTA and at the time of follow-up CCTA.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • patients underwent two or more clinically indicated CCTA with 64-detector rows or greater for CAD evaluation
  • patients underwent at least 2 year interval between the baseline and follow-up CCTA
Read More
Exclusion Criteria
  • poor image quality of CCTA
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in plaque volume and composition detected by follow up CCTA2 years
Secondary Outcome Measures
NameTimeMethod
Myocardial infarction (yes or no)2 years
Revascularization (yes or no)2 years
Cardiac mortality (yes or no)2 years
Unstable angina requiring hospitalization (yes or no)2 years
© Copyright 2025. All Rights Reserved by MedPath